Cookson Peirce & CO Inc Novartis Ag Transaction History

Cookson Peirce & CO Inc

$2.1 Billion
Q3 2024

A detailed history of Cookson Peirce & CO Inc transactions in Novartis Ag stock. As of the latest transaction made, Cookson Peirce & CO Inc holds 7,056 shares of NVS stock, worth $693,957. This represents 0.04% of its overall portfolio holdings.

Number of Shares

7,056

Previous 7,047 0.13%

Holding current value

$693,957

Previous $750,000 8.13%

% of portfolio

0.04%

Previous 0.04%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$106.13 - $120.89 $955 - $1,088	9 Added 0.13%	7,056 $811,000
Q2 2024 Aug 13, 2024	SELL	$92.57 - $107.37 $16,014 - $18,575	-173 Reduced 2.4%	7,047 $750,000
Q1 2024 Apr 23, 2024	SELL	$95.27 - $108.47 $4,001 - $4,555	-42 Reduced 0.58%	7,220 $698,000
Q4 2023 Jan 30, 2024	BUY	$92.27 - $101.54 $11,718 - $12,895	127 Added 1.78%	7,262 $733,000
Q3 2023 Nov 07, 2023	BUY	$94.73 - $105.13 $675,898 - $750,102	7,135 New	7,135 $727,000
Q2 2022 Jul 20, 2022	BUY	$80.52 - $93.75 $14.1 Million - $16.5 Million	175,674 New	175,674 $14.8 Million
Q3 2020 Nov 04, 2020	SELL	$82.14 - $91.0 $554,937 - $614,796	-6,756 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$80.93 - $91.1 $15,943 - $17,946	-197 Reduced 2.83%	6,756 $590,000
Q1 2020 May 04, 2020	BUY	$70.67 - $99.01 $24,522 - $34,356	347 Added 5.25%	6,953 $573,000
Q4 2019 Jan 27, 2020	BUY	$84.35 - $95.37 $8,856 - $10,013	105 Added 1.62%	6,606 $625,000
Q3 2019 Nov 05, 2019	BUY	$85.54 - $94.26 $45,421 - $50,052	531 Added 8.89%	6,501 $564,000
Q2 2019 Jul 31, 2019	BUY	$75.4 - $92.8 $247,538 - $304,662	3,283 Added 122.18%	5,970 $0
Q1 2019 May 01, 2019	BUY	$75.32 - $86.15 $13,331 - $15,248	177 Added 7.05%	2,687 $258,000
Q4 2018 Feb 07, 2019	BUY	$73.66 - $82.02 $184,886 - $205,870	2,510 New	2,510 $192,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cookson Peirce & CO Inc with notifications on news.

Account

Cookson Peirce & CO Inc Novartis Ag Transaction History